NADAC acquisition cost data for NORA-BE TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 52544062928 | $0.1519 | 2022-12-21 | Rx |
| 52544062928 | $0.1519 | 2022-12-21 | Rx |
Generic: Norethindrone | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $67.4K | 2,121 | 689 | $0.5145 |
| 2020 | $69.3K | 2,151 | 693 | $0.5001 |
| 2021 | $65.4K | 2,083 | 633 | $0.4656 |
| 2022 | $60.3K | 1,948 | 599 | $0.4556 |
| 2023 | $59.3K | 1,925 | 598 | $0.4579 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $26.6K | 804 | 293 |
| New York | $3.8K | 78 | 25 |
| Colorado | $2.4K | 70 | 24 |
| Oklahoma | $2.3K | 55 | 12 |
| Maryland | $1.9K | 65 | 20 |
| Texas | $1.9K | 70 | 17 |
| Washington | $1.6K | 53 | 18 |
| Minnesota | $1.4K | 38 | 17 |
| Pennsylvania | $1.4K | 49 | 15 |
| Georgia | $1.3K | 55 | 16 |
| Hawaii | $1.2K | 36 | 12 |
| Oregon | $1.2K | 35 | 15 |
| Michigan | $897.41 | 30 | N/A |
| New Jersey | $819.12 | 42 | N/A |
| Louisiana | $764.38 | 55 | 12 |
| Arizona | $750.64 | 24 | N/A |
| Iowa | $705.91 | 26 | N/A |
| Ohio | $701.35 | 42 | N/A |
| Florida | $593.51 | 21 | N/A |
| North Carolina | $582.60 | 15 | N/A |
| South Carolina | $507.52 | 20 | N/A |
| Virginia | $505.06 | 22 | N/A |
| Connecticut | $461.39 | 15 | N/A |
| Illinois | $451.35 | 15 | N/A |
| Wisconsin | $433.89 | 18 | N/A |
| Indiana | $411.33 | 14 | N/A |
| New Mexico | $394.25 | 13 | N/A |
| Maine | $389.31 | 15 | N/A |
| Massachusetts | $386.85 | 12 | N/A |
| Alabama | $339.65 | 14 | N/A |
| Alaska | $297.30 | 19 | N/A |
| Mississippi | $269.95 | 16 | N/A |
| Rhode Island | $138.46 | 11 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.